BFDA Public Health Advisory on substandard product confirmed by the Thai Food and Drug Administration via the South East Asia Regulatory Network (SEARN)
Home Regulatory news and announcementsBFDA Public Health Advisory on substandard product confirmed by the Thai Food and Drug Administration via the South East Asia Regulatory Network (SEARN)

BFDA Public Health Advisory on substandard product confirmed by the Thai Food and Drug Administration via the South East Asia Regulatory Network (SEARN)

November 16, 2025| Regulatory news and announcements|

BFDA Public Safety AdvisoryDownload

Last modified: April 8, 2026

Previous:
Regulatory Notification on the Recall of Herbal Product COMPOUND HERB INHALER (HONGTHAI BRAND FORMULA 2)
Next:
Press release on ByHeart Infant Formula

Comments are closed.

Close Search Window
↑